Total Payments
$1,131
2022 Payments
$43.07
Companies
22
Transactions
38
Medicare Patients
12,866
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$946.01 (83.6%)
Travel$185.00 (16.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $946.01 | 37 | 83.6% |
| Travel and Lodging | $185.00 | 1 | 16.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $268.49 | 2 | $0 (2019) |
| DePuy Synthes Sales Inc. | $140.37 | 5 | $0 (2021) |
| Genentech USA, Inc. | $131.94 | 1 | $0 (2019) |
| Endocare, Inc. | $74.30 | 1 | $0 (2017) |
| Amgen Inc. | $59.17 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.18 | 3 | $0 (2020) |
| GE HEALTHCARE | $41.18 | 3 | $0 (2021) |
| Eisai Inc. | $40.16 | 2 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $36.34 | 1 | $0 (2018) |
| Medtronic USA, Inc. | $36.08 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $43.07 | 2 | Daiichi Sankyo Inc. ($28.43) |
| 2021 | $123.03 | 7 | DePuy Synthes Sales Inc. ($50.19) |
| 2020 | $113.68 | 5 | DePuy Synthes Sales Inc. ($34.72) |
| 2019 | $548.21 | 10 | Stryker Corporation ($268.49) |
| 2018 | $125.85 | 6 | Alexion Pharmaceuticals, Inc. ($36.34) |
| 2017 | $177.17 | 8 | Endocare, Inc. ($74.30) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2022 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Hematology/Oncology | ||||||
| 11/18/2021 | DePuy Synthes Sales Inc. | EMBOTRAP (Device) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Neurovascular | ||||||
| 06/29/2021 | DePuy Synthes Sales Inc. | EMBOTRAP (Device) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Neurovascular | ||||||
| 06/23/2021 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $11.18 | General |
| 03/17/2021 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| 03/17/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Hematology/Oncology | ||||||
| 01/27/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Oncology | ||||||
| 01/12/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2020 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Oncology | ||||||
| 11/17/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $15.24 | General |
| 08/27/2020 | DePuy Synthes Sales Inc. | EMBOTRAP II Revascularization Device (Device) | Food and Beverage | In-kind items and services | $34.72 | General |
| Category: Neurovascular | ||||||
| 02/04/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.46 | General |
| Category: Oncology | ||||||
| 01/22/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $20.23 | General |
| 12/02/2019 | Medtronic USA, Inc. | Solitaire (Device) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Stents | ||||||
| 11/19/2019 | Siemens Medical Solutions USA, Inc. | Artis Q.zen (Device), SOMATOM Edge | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 10/29/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| 08/02/2019 | Terumo Medical Corporation | AngioSeal (Device), TR Band | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Vascular Access | ||||||
| 07/23/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Oncology | ||||||
| 06/11/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $131.94 | General |
| 04/04/2019 | DePuy Synthes Sales Inc. | EMBOTRAP II Revascularization Device (Device) | Food and Beverage | In-kind items and services | $39.93 | General |
| Category: Neurovascular | ||||||
| 03/30/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Travel and Lodging | Cash or cash equivalent | $185.00 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 03/30/2019 | Stryker Corporation | IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) | Food and Beverage | Cash or cash equivalent | $83.49 | General |
| Category: INTERVENTIONAL SPINE | ||||||
| 01/29/2019 | DePuy Synthes Sales Inc. | EMBOTRAP II Revascularization Device (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Neurovascular | ||||||
| 11/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 65 | 3,709 | 26,421 | $1.4M | $388,692 |
| 2022 | 67 | 3,506 | 40,204 | $2.0M | $502,127 |
| 2021 | 68 | 3,221 | 38,592 | $1.7M | $425,799 |
| 2020 | 56 | 2,430 | 32,593 | $1.4M | $310,789 |
Total Patients
12,866
Total Services
137,810
Medicare Billing
$1.6M
Procedure Codes
321
All Medicare Procedures & Services
321 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 96 | 99 | $297,000 | $119,432 | 40.2% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 114 | 117 | $58,500 | $46,937 | 80.2% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 18 | 18 | $54,000 | $21,657 | 40.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 143 | 143 | $65,942 | $19,156 | 29.1% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 49 | 49 | $129,213 | $12,309 | 9.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 40 | 40 | $32,800 | $8,856 | 27.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 57 | 58 | $23,924 | $8,059 | 33.7% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 229 | 239 | $33,025 | $7,292 | 22.1% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 70 | 70 | $56,000 | $6,757 | 12.1% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 45 | 45 | $59,949 | $6,468 | 10.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 19 | 19 | $18,620 | $6,451 | 34.6% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 42 | 42 | $61,288 | $6,009 | 9.8% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Office | 2023 | 18 | 19 | $38,000 | $5,790 | 15.2% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 37 | 38 | $46,848 | $5,301 | 11.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 19 | 38 | $6,156 | $4,939 | 80.2% |
| 71275 | Ct scan of blood vessels of chest with contrast | Office | 2023 | 24 | 24 | $24,000 | $4,741 | 19.8% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 586 | 670 | $19,568 | $4,512 | 23.1% |
| 70498 | Ct scan of blood vessels of neck with contrast | Office | 2023 | 24 | 24 | $24,000 | $4,274 | 17.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 51 | 53 | $17,115 | $4,248 | 24.8% |
| 70496 | Ct scan of blood vessels of head with contrast | Office | 2023 | 21 | 21 | $21,000 | $4,172 | 19.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 20 | 80 | $6,560 | $3,882 | 59.2% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2023 | 29 | 29 | $38,063 | $3,874 | 10.2% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 63 | 63 | $13,797 | $3,418 | 24.8% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 47 | 47 | $36,872 | $3,415 | 9.3% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Office | 2023 | 14 | 14 | $8,050 | $3,333 | 41.4% |
About Dr. David Turetsky, MD
Dr. David Turetsky, MD is a Body Imaging healthcare provider based in Daytona Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093759599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Turetsky, MD has received a total of $1,131 in payments from pharmaceutical and medical device companies, with $43.07 received in 2022. These payments were reported across 38 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($946.01).
As a Medicare-enrolled provider, Turetsky has provided services to 12,866 Medicare beneficiaries, totaling 137,810 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 321 distinct procedure/service records.
Ad
Practice Information
- Specialty Body Imaging
- Other Specialties Neuroradiology, Nuclear Radiology
- Location Daytona Beach, FL
- Active Since 06/15/2006
- Last Updated 09/02/2025
- Taxonomy Code 2085B0100X
- Entity Type Individual
- NPI Number 1093759599
Products in Payments
- IVS - VERTEBRAL AUGMENTATION PRODUCTS (Device) $268.49
- EMBOTRAP II Revascularization Device (Device) $90.18
- Endocare Cryocare System (Medical Supply) $74.30
- Neulasta (Biological) $59.17
- EMBOTRAP (Device) $50.19
- Lenvima (Drug) $40.16
- SOLIRIS (Drug) $36.34
- JAKAFI (Drug) $28.82
- ENHERTU (Drug) $28.43
- Solitaire (Device) $25.31
- NINLARO (Drug) $24.95
- Aliqopa (Drug) $24.53
- Interventional Products (Device) $22.85
- AngioSeal (Device) $22.29
- LYNPARZA (Drug) $21.04
- VYXEOS (Drug) $20.76
- TUKYSA (Drug) $20.03
- RYDAPT (Drug) $12.94
- Artis Q.zen (Device) $12.76
- KISQALI (Drug) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Body Imaging Doctors in Daytona Beach
Dr. John Gianini, Md, MD
Body Imaging — Payments: $5,041
Body Imaging $5,041
Thomas Green, M.d, M.D
Body Imaging — Payments: $1,969
Body Imaging $1,969
Dr. Daniel Miles, M.d, M.D
Body Imaging — Payments: $963.09
Body Imaging $963.09
Dr. Steven Miles, M.d, M.D
Body Imaging — Payments: $456.23
Body Imaging $456.23
Dr. John Agles, M.d, M.D
Body Imaging — Payments: $224.12
Body Imaging $224.12
Dr. Thomas Yuschok, M.d, M.D
Body Imaging — Payments: $85.56
Body Imaging $85.56